International Equities Index Fund
VALIC Co I · 1 share class
Fund classification
Classified from what the fund holds · as of 2026 Q2
International Equities Index Fund is a developed international equity index fund that tracks the MSCI EAFE Index.
- Asset class
- Equity
- Region
- Developed international
- Management
- Index (passive)
- Fund type
- Open-end fund
Fund profile
As filed in the prospectus · 2025 Q3
The Fund seeks long-term capital growth through investments in equity securities that, as a group, are expected to provide investment results closely corresponding to the performance of the MSCI EAFE Index (net) (the Index).
The fund is managed by a subadviser to track the MSCI EAFE Index, which measures large- and mid-cap stocks in developed countries outside the U.S. The subadviser may purchase all index constituents in their exact proportions or use optimization—a statistical technique to select a sample of stocks whose industry weightings, market capitalizations, and fundamental characteristics closely approximate those of the Index. Because the fund may employ sampling rather than holding all index constituents, its performance may diverge from the Index. The fund may lend securities to generate additional income.
| Share class | Gross | Net |
|---|---|---|
| VCIEX | 0.42% | 0.39% |
Net is what a holder pays after the adviser's contractual waiver; gross is before it. A waiver can expire.
Portfolio turnover 12.00% · as of 2025 Q3
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 98.75% |
| Cash & short-term | 0.84% |
| Derivatives | 0.04% |
Derivatives are shown at market value, not notional exposure.
Latest quarter
What changed since the fund's previous filing
Largest new: Roche Holding AG, Ibiden Co Ltd, SUNB, Tower Semiconductor Ltd, BAWAG Group AG, Shimizu Corp, Wise Group PLC, Italgas SpA
Largest exited: Roche Holding AG, Ashtead Group PLC, Wise PLC, JDE Peet's NV, Edenred SE, DCC PLC, IMCD NV, Trend Micro Inc/Japan
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
May 2026 has been filed since the trailing figures were struck, so it is not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| — | ASML Holding NV | 2.81% | $1,615.23 | $61.31M | 38.0K |
| — | HSBC Holdings PLC | 1.45% | $18.77 | $31.52M | 1.7M |
| — | Roche Holding AG | 1.33% | $421.88 | $28.98M | 68.7K |
| — | AstraZeneca PLC | 1.29% | $185.87 | $28.19M | 151.7K |
| — | Novartis AG | 1.29% | $150.94 | $28.06M | 185.9K |
| — | Nestle SA | 1.18% | $101.77 | $25.64M | 251.9K |
| — | Shell PLC | 1.07% | $41.99 | $23.40M | 557.3K |
| — | Siemens AG | 1.07% | $314.69 | $23.39M | 74.3K |
| — | BHP Group Ltd | 1.02% | $44.79 | $22.24M | 496.7K |
| — | Mitsubishi UFJ Financial Group Inc | 0.95% | $18.83 | $20.76M | 1.1M |
Reported price is the fund's own reported value divided by its own reported shares at 2026-05-31 — not a live quote, and not what the fund paid.
Top 10 positions are 13.46% of net assets, top 25 24.88%, across 691 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free